Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says

The widespread use of powerful new weight-loss drugs in the United States could boost gross domestic product by 1% in the coming years as lower obesity-related complications are likely to boost workplace efficiency, according to Goldman Sachs.